Kenneth I. Kaitin

Entity
Individual
Business address
C/O Tufts Cntr For The Study Of Drug Dev, 75 Kneeland St, Suite 1100, 02111 Boston, MA
Insider ownership signature
/s/ Diantha Duvall, Attorney-in-fact
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Kenneth I. Kaitin has filed 34 SEC EDGAR filings since 4/16/2004

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 May 22, 2025 May 20, 2025 000-30347
4 Open Document Open Filing FORM 4 Jan 30, 2025 Jan 28, 2025 000-30347
4 Open Document Open Filing FORM 4 May 23, 2024 May 21, 2024 000-30347
4 Open Document Open Filing FORM 4 Jan 24, 2023 Jan 23, 2023 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 31, 2022 Jan 31, 2022 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 29, 2021 Jan 28, 2021 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Mar 4, 2020 Mar 2, 2020 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 25, 2019 Jan 23, 2019 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 23, 2019 Jan 21, 2019 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 24, 2018 Jan 22, 2018 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jun 2, 2017 May 31, 2017 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Mar 2, 2017 Feb 28, 2017 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION May 27, 2016 May 26, 2016 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 21, 2016 Jan 19, 2016 000-30347
4 Open Document Open Filing FORM 4 SUBMISSION Jan 28, 2015 Jan 26, 2015 000-30347
4 Open Document Open Filing 2014 ANNUAL GRANT Jan 28, 2014 Jan 27, 2014 000-30347